Clinical Trials
2 trialsNCT06047535 2023-09-21
Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) Combined With Isotretinoin for Maintenance Treatment of Patients With High-Risk Neuroblastoma in First Complete Response.
SciClone Pharmaceuticals
Phase 4 Not yet recruiting
NCT04864717 2021-09-08
Doxycycline vs Isotretinoin for Acneiform Eruptions of TKI
Lady Davis Institute
Phase 4 Unknown